DNA Sequencing Market Size To Hit US$ 40.64 Billion By 2030

The global DNA sequencing market size is expected to hit around USD 40.64 billion by 2030 and progressing a CAGR of 40.64% over the forecast period 2022 to 2030.

DNA Sequencing Market Size 2017 to 2030

The on DNA sequencing Market, which proviVdes a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1189

Report Scope of the DNA Sequencing Market

Report Highlights	Details
Market Size	US$ 40.64 billion by 2030
Growth Rate	CAGR of 17.5% from 2021 to 2030
Largest Market	North America
Fastest Growing Market	Asia Pacific
Base Year	2021
Forecast Period	2021 to 2030
Segments Covered	Product, technology, Application, End Use

A recent report provides crucial insights along with application based and forecast information in the Global DNA sequencing Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the DNA sequencing market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global DNA sequencing market are included as given below:

DNA sequencing Market Key Players

Agilent Technologies
Illumina, Inc.
QIAGEN
Perkin Elmer
Thermo Fisher Scientific
Hoffmann-La Roche Ltd.
Macrogen, Inc.
Bio-Rad Laboratories, Inc.
Oxford Nanopore Technologies Ltd.
Myriad Genetics

Market Segments

By Product

Instruments
Consumables
Services

By Technology

Third Generation DNA Sequencing
Next-Generation Sequencing
Sanger Sequencing

By Application

Clinical Investigation
Oncology
Forensics & Agrigenomics
Reproductive Health
HLA Typing
Others

By End-Use

Clinical Research
Academic Research
Biotechnology & Pharmaceutical Companies
Hospitals & Clinics
Others

By Geography

North America

U.S.
Canada

Europe

Germany
France
United Kingdom
Rest of Europe

Asia Pacific

China
Japan
India
Southeast Asia
Rest of Asia Pacific

Latin America

Brazil
Rest of Latin America

Middle East & Africa (MEA)

GCC
North Africa
South Africa
Rest of Middle East & Africa

Report Objectives

To define, describe, and forecast the global DNA sequencing market based on product, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the DNA sequencing market

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. DNA Sequencing Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on DNA Sequencing Market

5.1. Covid-19: DNA Sequencing Industry Impact
5.2. DNA Sequencing Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and DNA Sequencing Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for DNA Sequencing Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. DNA Sequencing Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing prevalence of cancer
6.1.1.2. Technological advances in next-generation sequencing technologies
6.1.2. Market Restraints
6.1.2.1. Stringent regulations
6.1.3. Market Opportunities
6.1.3.1. Rising demand for precision medicine
6.1.3.2. Technological advancements

Chapter 7. Global DNA Sequencing Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. DNA Sequencing Market Revenue by Market Players (2016 -2019)
7.1.1.2. DNA Sequencing Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global DNA Sequencing Market, By Product

8.1. DNA Sequencing Market, by Product, 2017 - 2030
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2017 - 2030)
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast (2017 - 2030)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2017 - 2030)

Chapter 9. Global DNA Sequencing Market, By Technology

9.1. DNA Sequencing Market, by Technology, 2017 - 2030
9.1.1. Third Generation DNA Sequencing
9.1.1.1. Market Revenue and Forecast (2017 - 2030)
9.1.2. Next-Generation Sequencing
9.1.2.1. Market Revenue and Forecast (2017 - 2030)
9.1.3. Next-Generation Sequencing
9.1.3.1. Market Revenue and Forecast (2017 - 2030)

Chapter 10. Global DNA Sequencing Market, By Application

10.1. DNA Sequencing Market, by Application, 2017 - 2030
10.1.1. Clinical Investigation
10.1.1.1. Market Revenue and Forecast (2017 - 2030)
10.1.2. Oncology
10.1.2.1. Market Revenue and Forecast (2017 - 2030)
10.1.3. Forensics & Agrigenomics
10.1.3.1. Market Revenue and Forecast (2017 - 2030)
10.1.4. Reproductive Health
10.1.4.1. Market Revenue and Forecast (2017 - 2030)
10.1.5. HLA Typing
10.1.5.1. Market Revenue and Forecast (2017 - 2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2017 - 2030)

Chapter 11. Global DNA Sequencing Market, By End Use

11.1. DNA Sequencing Market, by End-Use, 2017 - 2030
11.1.1. Clinical Research
11.1.1.1. Market Revenue and Forecast (2017 - 2030)
11.1.2. Academic Research
11.1.2.1. Market Revenue and Forecast (2017 - 2030)
11.1.3. Biotechnology & Pharmaceutical Companies
11.1.3.1. Market Revenue and Forecast (2017 - 2030)
11.1.4. Hospitals & Clinics
11.1.4.1. Market Revenue and Forecast (2017 - 2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2017 - 2030)

Chapter 12. Global DNA Sequencing Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product(2017 - 2030)
12.1.2. Market Revenue Forecast by Technology(2017 - 2030)
12.1.3. Market Revenue Forecast by Application (2017 - 2030)
12.1.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017 - 2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017 - 2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Product (2017 - 2030)
12.2.2. Market Revenue Forecast by Technology (2017 - 2030)
12.2.3. Market Revenue Forecast by Application (2017 - 2030)
12.2.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017 - 2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017 - 2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017 - 2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017 - 2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product (2017 - 2030)
12.3.2. Market Revenue Forecast by Technology (2017 - 2030)
12.3.3. Market Revenue Forecast by Application (2017 - 2030)
12.3.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017 - 2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017 - 2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017 - 2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017 - 2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product (2017 - 2030)
12.4.2. Market Revenue Forecast by Technology (2017 - 2030)
12.4.3. Market Revenue Forecast by Application (2017 - 2030)
12.4.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017 - 2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017 - 2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product (2017 - 2030)
12.5.2. Market Revenue Forecast by Technology (2017 - 2030)
12.5.3. Market Revenue Forecast by Application (2017 - 2030)
12.5.4. Market Revenue Forecast by End-Use (2017 - 2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017 - 2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017 - 2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017 - 2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017 - 2030)

Chapter 13. Company Profiles

13.1. Agilent Technologies
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.1.4. Recent Developments and Strategies
13.2. Illumina, Inc.
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.2.4. Recent Developments and Strategies
13.3. QIAGEN
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.3.4. Recent Developments and Strategies
13.4. Perkin Elmer
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.4.4. Recent Developments and Strategies
13.5. Thermo Fisher Scientific
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.5.4. Recent Developments and Strategies
13.6. F. Hoffmann-La Roche Ltd.
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.6.4. Recent Developments and Strategies
13.7. Macrogen, Inc.
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.7.4. Recent Developments and Strategies
13.8. Bio-Rad Laboratories, Inc.
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.8.4. Recent Developments and Strategies
13.9. Oxford Nanopore Technologies Ltd.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.9.4. Recent Developments and Strategies
13.10. Myriad Genetics
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2017 - 2020)
13.10.4. Recent Developments and Strategies